Torul, Damla
Omezli, Mehmet Melih
Avci, Tolunay
Funding for this research was provided by:
Ordu Üniversitesi (A-2005)
Article History
Received: 18 November 2022
Accepted: 17 May 2023
First Online: 26 May 2023
Declarations
:
: This study was approved by Ordu University’s Institutional Review Board (No: 2019–30) and Turkish Medicines and Medical Devices Agency, Section of Clinical Trials, Republic of Turkey Ministry of Health (2019–77). The study was carried out in compliance with the principles of the Declaration of Helsinki and the CONSORT (Consolidated Standards of Reporting Trials) guidelines. The study has been registered at clinical trials (ID number NCT04507009).
: The study was explained to each participant who wished to participate before they were recruited, and their informed consent was obtained from all participants.
: The authors declare no competing interests.